Advertisement

Deregulation Is The Pathway To Greater Pharmaceutical Innovation

An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients who are waiting for effective treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *